Cheryl Zimberlin

Direttore/Membro del Consiglio presso

Indi Molecular, Inc.

Commercial Services

Health Technology

Finance

Profilo

Cheryl Zimberlin is currently the Director at Indi Molecular, Inc. and the Principal at Merck Ventures BV.
She previously worked as a Member-Supervisory Board at Vaximm AG.

Posizioni attive di Cheryl Zimberlin

Società	Posizione	Inizio
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Investitore di Private Equity	01/04/2019
Indi Molecular, Inc. Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Cheryl Zimberlin

Precedenti posizioni note di Cheryl Zimberlin

Società	Posizione	Fine
Vaximm AG Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Cheryl Zimberlin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Cheryl Zimberlin

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Vaximm AG Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment	Commercial Services
Indi Molecular, Inc. Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents	Health Technology
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Finance